These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

594 related articles for article (PubMed ID: 21384419)

  • 21. Synthesis, molecular docking and evaluation of thiazolyl-pyrazoline derivatives as EGFR TK inhibitors and potential anticancer agents.
    Lv PC; Li DD; Li QS; Lu X; Xiao ZP; Zhu HL
    Bioorg Med Chem Lett; 2011 Sep; 21(18):5374-7. PubMed ID: 21802290
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synthesis, spectroscopy (IR, multinuclear NMR, ESI-MS), diffraction, density functional study and in vitro antiproliferative activity of pyrazole-beta-diketone dihalotin(IV) compounds on 5 melanoma cell lines.
    Pettinari C; Caruso F; Zaffaroni N; Villa R; Marchetti F; Pettinari R; Phillips C; Tanski J; Rossi M
    J Inorg Biochem; 2006 Jan; 100(1):58-69. PubMed ID: 16313961
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synthesis, structure, and in vitro antitumor activity of some glycoside derivatives of ferrocenyl-chalcones and ferrocenyl-pyrazolines.
    Zsoldos-Mády V; Csámpai A; Szabó R; Mészáros-Alapi E; Pásztor J; Hudecz F; Sohár P
    ChemMedChem; 2006 Oct; 1(10):1119-25. PubMed ID: 16944543
    [TBL] [Abstract][Full Text] [Related]  

  • 24. 3,5-bis(3'-indolyl)pyrazoles, analogues of marine alkaloid nortopsentin: synthesis and antitumor properties.
    Diana P; Carbone A; Barraja P; Martorana A; Gia O; DallaVia L; Cirrincione G
    Bioorg Med Chem Lett; 2007 Nov; 17(22):6134-7. PubMed ID: 17911018
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Synthesis of 1-benzyl-3-(5-hydroxymethyl-2-furyl)selenolo[3,2-c]pyrazole derivatives as new anticancer agents.
    Chou LC; Huang LJ; Hsu MH; Fang MC; Yang JS; Zhuang SH; Lin HY; Lee FY; Teng CM; Kuo SC
    Eur J Med Chem; 2010 Apr; 45(4):1395-402. PubMed ID: 20097456
    [TBL] [Abstract][Full Text] [Related]  

  • 26. New synthesis of two tridentate bipyrazolic compounds and their cytotoxic activity tumor cell lines.
    El Kodadi M; Benamar M; Ibrahim B; Zyad A; Malek F; Touzani R; Ramdani A; Melhaoui A
    Nat Prod Res; 2007 Sep; 21(11):947-52. PubMed ID: 17691042
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Synthesis and in vitro antitumor activity of new 4,5-dihydropyrazole derivatives.
    Congiu C; Onnis V; Vesci L; Castorina M; Pisano C
    Bioorg Med Chem; 2010 Sep; 18(17):6238-48. PubMed ID: 20702096
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synthesis and bioactivities of novel pyrazole and triazole derivatives containing 5-phenyl-2-furan.
    Cui ZN; Shi YX; Cui JR; Ling Y; Li BJ; Yang XL
    Chem Biol Drug Des; 2012 Jan; 79(1):121-7. PubMed ID: 22023821
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Design and synthesis of new potent anticancer pyrazoles with high FLT3 kinase inhibitory selectivity.
    El-Deeb IM; Lee SH
    Bioorg Med Chem; 2010 Jun; 18(11):3961-73. PubMed ID: 20472440
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification of antitumor activity of pyrazole oxime ethers.
    Park HJ; Lee K; Park SJ; Ahn B; Lee JC; Cho H; Lee KI
    Bioorg Med Chem Lett; 2005 Jul; 15(13):3307-12. PubMed ID: 15922597
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Synthesis and structure-activity relationships of novel 1-arylmethyl-3-aryl-1H-pyrazole-5-carbohydrazide hydrazone derivatives as potential agents against A549 lung cancer cells.
    Xia Y; Fan CD; Zhao BX; Zhao J; Shin DS; Miao JY
    Eur J Med Chem; 2008 Nov; 43(11):2347-53. PubMed ID: 18313806
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Design and synthesis of novel tetrahydro-2H-Pyrano[3,2-c]pyridazin-3(6H)-one derivatives as potential anticancer agents.
    Al-Tel TH
    Eur J Med Chem; 2010 Dec; 45(12):5724-31. PubMed ID: 20884086
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Synthesis and anti-tumor activities of some new pyridines and pyrazolo[1,5-a]pyrimidines.
    Ahmed OM; Mohamed MA; Ahmed RR; Ahmed SA
    Eur J Med Chem; 2009 Sep; 44(9):3519-23. PubMed ID: 19398146
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Design and synthesis of novel 3,4-disubstituted pyrazoles for nanomedicine applications against malignant gliomas.
    Comes Franchini M; Bonini BF; Camaggi CM; Gentili D; Pession A; Rani M; Strocchi E
    Eur J Med Chem; 2010 May; 45(5):2024-33. PubMed ID: 20129719
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Synthesis of 1-substituted 3-aryl-5-aryl(hetaryl)-2-pyrazolines and study of their antitumor activity.
    Insuasty B; Chamizo L; Muñoz J; Tigreros A; Quiroga J; Abonía R; Nogueras M; Cobo J
    Arch Pharm (Weinheim); 2012 Apr; 345(4):275-86. PubMed ID: 22105771
    [TBL] [Abstract][Full Text] [Related]  

  • 36. 5-Substituted [1]pyrindine derivatives with antiproliferative activity.
    Kolb S; Goddard ML; Loukaci A; Mondésert O; Ducommun B; Braud E; Garbay C
    Eur J Med Chem; 2010 Mar; 45(3):896-901. PubMed ID: 19969400
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Polysubstituted pyrazoles, part 6. Synthesis of some 1-(4-chlorophenyl)-4-hydroxy-1H-pyrazol-3-carbonyl derivatives linked to nitrogenous heterocyclic ring systems as potential antitumor agents.
    Rostom SA
    Bioorg Med Chem; 2010 Apr; 18(7):2767-76. PubMed ID: 20207545
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Synthesis and antiproliferative evaluation of 23-hydroxybetulinic acid derivatives.
    Lan P; Wang J; Zhang DM; Shu C; Cao HH; Sun PH; Wu XM; Ye WC; Chen WM
    Eur J Med Chem; 2011 Jun; 46(6):2490-502. PubMed ID: 21496972
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Synthesis and antiproliferative activity of novel diaryl ureas possessing a 4H-pyrido[1,2-a]pyrimidin-4-one group.
    Yao P; Zhai X; Liu D; Qi BH; Tan HL; Jin YC; Gong P
    Arch Pharm (Weinheim); 2010 Jan; 343(1):17-23. PubMed ID: 19927308
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Synthesis of novel 3,5-diaryl pyrazole derivatives using combinatorial chemistry as inhibitors of tyrosinase as well as potent anticancer, anti-inflammatory agents.
    Bandgar BP; Totre JV; Gawande SS; Khobragade CN; Warangkar SC; Kadam PD
    Bioorg Med Chem; 2010 Aug; 18(16):6149-55. PubMed ID: 20638287
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 30.